Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC) and Becton Dickinson (BDX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenet Healthcare (THC – Research Report) and Becton Dickinson (BDX – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tenet Healthcare (THC)
UBS analyst A.J. Rice maintained a Buy rating on Tenet Healthcare yesterday and set a price target of $260.00. The company’s shares closed last Monday at $188.03.
According to TipRanks.com, Rice is a 5-star analyst with an average return of
Tenet Healthcare has an analyst consensus of Strong Buy, with a price target consensus of $242.78, representing a 28.0% upside. In a report issued on January 22, RBC Capital also maintained a Buy rating on the stock with a $252.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Becton Dickinson (BDX)
Citi analyst Joanne Wuensch initiated coverage with a Buy rating on Becton Dickinson yesterday and set a price target of $233.00. The company’s shares closed last Monday at $201.91.
According to TipRanks.com, Wuensch is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Becton Dickinson with a $210.38 average price target.
